Kenneth Bruce Christopher, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Critical Illness | 56 | 2024 | 2722 | 8.550 |
Why?
|
Vitamin D Deficiency | 25 | 2024 | 1382 | 4.070 |
Why?
|
Vitamin D | 25 | 2024 | 3296 | 3.140 |
Why?
|
Intensive Care Units | 31 | 2024 | 3742 | 2.710 |
Why?
|
Cholecalciferol | 8 | 2024 | 548 | 2.610 |
Why?
|
Malnutrition | 9 | 2022 | 644 | 2.610 |
Why?
|
Metabolomics | 8 | 2024 | 1654 | 1.830 |
Why?
|
Nutritional Status | 9 | 2022 | 1612 | 1.530 |
Why?
|
Metabolome | 7 | 2024 | 986 | 1.520 |
Why?
|
Hospital Mortality | 16 | 2022 | 5283 | 1.440 |
Why?
|
Erythrocyte Indices | 5 | 2020 | 144 | 1.410 |
Why?
|
Acute Kidney Injury | 7 | 2018 | 1925 | 1.370 |
Why?
|
Parenteral Nutrition | 3 | 2023 | 659 | 1.350 |
Why?
|
Vascular Surgical Procedures | 4 | 2022 | 1490 | 1.200 |
Why?
|
Patient Discharge | 8 | 2022 | 3436 | 1.200 |
Why?
|
Vitamins | 6 | 2024 | 1632 | 1.120 |
Why?
|
Critical Care | 16 | 2024 | 2697 | 1.010 |
Why?
|
Boston | 20 | 2019 | 9324 | 0.980 |
Why?
|
Sepsis | 10 | 2017 | 2583 | 0.900 |
Why?
|
Survivors | 4 | 2017 | 2369 | 0.870 |
Why?
|
Surgical Procedures, Operative | 4 | 2020 | 1923 | 0.850 |
Why?
|
Nutrition Assessment | 3 | 2022 | 728 | 0.850 |
Why?
|
Kynurenine | 1 | 2022 | 141 | 0.790 |
Why?
|
End Stage Liver Disease | 2 | 2016 | 352 | 0.780 |
Why?
|
Vascular Diseases | 2 | 2021 | 1160 | 0.770 |
Why?
|
Protein-Energy Malnutrition | 1 | 2022 | 189 | 0.760 |
Why?
|
Cross Infection | 3 | 2015 | 1438 | 0.740 |
Why?
|
Hospitalization | 11 | 2017 | 10692 | 0.710 |
Why?
|
Logistic Models | 18 | 2019 | 13230 | 0.700 |
Why?
|
Basal Metabolism | 1 | 2021 | 161 | 0.680 |
Why?
|
Enteral Nutrition | 3 | 2023 | 792 | 0.640 |
Why?
|
Middle Aged | 64 | 2024 | 220307 | 0.630 |
Why?
|
Odds Ratio | 12 | 2017 | 9630 | 0.590 |
Why?
|
Aged | 50 | 2024 | 168773 | 0.580 |
Why?
|
Smoke Inhalation Injury | 1 | 2017 | 47 | 0.570 |
Why?
|
Erythroblasts | 1 | 2017 | 142 | 0.560 |
Why?
|
Emergencies | 3 | 2018 | 1217 | 0.560 |
Why?
|
Graft Rejection | 10 | 2022 | 4438 | 0.540 |
Why?
|
Male | 75 | 2024 | 359943 | 0.540 |
Why?
|
Hypernatremia | 1 | 2016 | 78 | 0.520 |
Why?
|
Female | 68 | 2024 | 391766 | 0.500 |
Why?
|
Cohort Studies | 20 | 2024 | 41340 | 0.500 |
Why?
|
Community-Acquired Infections | 3 | 2013 | 468 | 0.490 |
Why?
|
Liver Function Tests | 1 | 2016 | 522 | 0.460 |
Why?
|
Eosinophils | 1 | 2019 | 947 | 0.460 |
Why?
|
Risk Factors | 26 | 2022 | 73999 | 0.460 |
Why?
|
Aged, 80 and over | 22 | 2021 | 58838 | 0.450 |
Why?
|
Liver Failure | 1 | 2016 | 250 | 0.450 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 869 | 0.430 |
Why?
|
Wounds and Injuries | 2 | 2016 | 2483 | 0.430 |
Why?
|
APACHE | 4 | 2017 | 267 | 0.410 |
Why?
|
Patient Readmission | 5 | 2021 | 3249 | 0.410 |
Why?
|
Humans | 86 | 2024 | 760239 | 0.410 |
Why?
|
Acid-Base Equilibrium | 1 | 2013 | 181 | 0.400 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 621 | 0.400 |
Why?
|
Craniotomy | 1 | 2016 | 741 | 0.390 |
Why?
|
Erythrocyte Volume | 1 | 2011 | 28 | 0.390 |
Why?
|
Residence Characteristics | 2 | 2012 | 2086 | 0.390 |
Why?
|
Renal Replacement Therapy | 2 | 2018 | 281 | 0.380 |
Why?
|
Severity of Illness Index | 4 | 2016 | 15818 | 0.370 |
Why?
|
Risk Assessment | 9 | 2021 | 23942 | 0.370 |
Why?
|
Retrospective Studies | 26 | 2022 | 80414 | 0.370 |
Why?
|
Blood Urea Nitrogen | 1 | 2011 | 186 | 0.370 |
Why?
|
Health Status Indicators | 2 | 2014 | 967 | 0.370 |
Why?
|
Poverty Areas | 1 | 2012 | 264 | 0.360 |
Why?
|
Energy Metabolism | 1 | 2021 | 2873 | 0.360 |
Why?
|
Adult | 38 | 2024 | 220718 | 0.350 |
Why?
|
Hyperkalemia | 1 | 2012 | 233 | 0.340 |
Why?
|
Cause of Death | 3 | 2021 | 3682 | 0.340 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2188 | 0.330 |
Why?
|
Gene Expression Profiling | 7 | 2004 | 9415 | 0.330 |
Why?
|
Heart Transplantation | 6 | 2007 | 3232 | 0.330 |
Why?
|
Mortality | 2 | 2019 | 2884 | 0.330 |
Why?
|
Academic Medical Centers | 4 | 2017 | 2756 | 0.320 |
Why?
|
Hospitals, Teaching | 4 | 2015 | 1155 | 0.320 |
Why?
|
Dietary Supplements | 5 | 2024 | 3396 | 0.310 |
Why?
|
Discriminant Analysis | 2 | 2018 | 222 | 0.300 |
Why?
|
Overweight | 2 | 2015 | 2409 | 0.290 |
Why?
|
Endovascular Procedures | 1 | 2021 | 2179 | 0.280 |
Why?
|
Clostridium Infections | 1 | 2014 | 558 | 0.280 |
Why?
|
Bacteremia | 1 | 2013 | 979 | 0.270 |
Why?
|
Phenotype | 1 | 2024 | 16588 | 0.270 |
Why?
|
Multivariate Analysis | 6 | 2017 | 12050 | 0.260 |
Why?
|
Burns | 1 | 2017 | 1863 | 0.260 |
Why?
|
Creatinine | 1 | 2011 | 1898 | 0.250 |
Why?
|
Time Factors | 9 | 2021 | 39928 | 0.240 |
Why?
|
Cerebral Hemorrhage | 1 | 2016 | 2656 | 0.240 |
Why?
|
Nutrition Therapy | 2 | 2016 | 101 | 0.230 |
Why?
|
Graft Survival | 8 | 2022 | 3806 | 0.230 |
Why?
|
Language | 1 | 2013 | 1537 | 0.230 |
Why?
|
Sex Factors | 5 | 2021 | 10534 | 0.220 |
Why?
|
Magnesium Deficiency | 2 | 2020 | 48 | 0.220 |
Why?
|
Delirium | 1 | 2015 | 1667 | 0.220 |
Why?
|
N-Formylmethionine | 1 | 2022 | 14 | 0.210 |
Why?
|
Magnesium | 3 | 2022 | 809 | 0.210 |
Why?
|
Health Status | 1 | 2016 | 4071 | 0.210 |
Why?
|
Length of Stay | 4 | 2022 | 6410 | 0.210 |
Why?
|
Inflammation | 2 | 2021 | 10744 | 0.210 |
Why?
|
Obesity | 2 | 2015 | 12908 | 0.210 |
Why?
|
Transplants | 2 | 2007 | 206 | 0.200 |
Why?
|
Registries | 5 | 2021 | 8213 | 0.200 |
Why?
|
Treatment Outcome | 12 | 2023 | 64583 | 0.200 |
Why?
|
Kidney Transplantation | 3 | 2022 | 4226 | 0.200 |
Why?
|
Endpoint Determination | 2 | 2015 | 590 | 0.190 |
Why?
|
Major Histocompatibility Complex | 1 | 2004 | 927 | 0.190 |
Why?
|
Confidence Intervals | 3 | 2011 | 2923 | 0.190 |
Why?
|
Body Mass Index | 2 | 2015 | 12917 | 0.180 |
Why?
|
Plasmalogens | 1 | 2020 | 30 | 0.180 |
Why?
|
Postoperative Complications | 3 | 2020 | 15626 | 0.180 |
Why?
|
Hand Strength | 1 | 2023 | 456 | 0.180 |
Why?
|
Sphingomyelins | 1 | 2020 | 104 | 0.180 |
Why?
|
Selenium | 1 | 2023 | 416 | 0.170 |
Why?
|
Multigene Family | 2 | 2004 | 1077 | 0.170 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2022 | 269 | 0.170 |
Why?
|
Deficiency Diseases | 1 | 2020 | 74 | 0.170 |
Why?
|
Age Factors | 5 | 2016 | 18369 | 0.170 |
Why?
|
Poverty | 1 | 2011 | 2693 | 0.160 |
Why?
|
Placebos | 2 | 2020 | 1661 | 0.160 |
Why?
|
Hyperuricemia | 1 | 2021 | 224 | 0.160 |
Why?
|
Prognosis | 7 | 2020 | 29547 | 0.160 |
Why?
|
Propensity Score | 2 | 2016 | 1906 | 0.150 |
Why?
|
Lysophospholipids | 1 | 2020 | 338 | 0.150 |
Why?
|
Placebo Effect | 1 | 2021 | 518 | 0.150 |
Why?
|
Diabetes Mellitus | 3 | 2024 | 5834 | 0.150 |
Why?
|
Multiple Organ Failure | 2 | 2022 | 386 | 0.140 |
Why?
|
Mice, Inbred BALB C | 7 | 2007 | 6206 | 0.140 |
Why?
|
Wasting Syndrome | 1 | 2017 | 97 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 787 | 0.140 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15252 | 0.140 |
Why?
|
Body Surface Area | 1 | 2017 | 197 | 0.140 |
Why?
|
Hypoxanthine | 1 | 2016 | 28 | 0.140 |
Why?
|
Activities of Daily Living | 2 | 2023 | 2417 | 0.130 |
Why?
|
Preoperative Period | 1 | 2018 | 550 | 0.130 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2016 | 65 | 0.130 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12420 | 0.130 |
Why?
|
Aftercare | 1 | 2022 | 911 | 0.130 |
Why?
|
Kidney Function Tests | 2 | 2016 | 675 | 0.130 |
Why?
|
Double-Blind Method | 5 | 2023 | 12314 | 0.130 |
Why?
|
Uric Acid | 1 | 2021 | 808 | 0.130 |
Why?
|
Trauma Severity Indices | 1 | 2017 | 478 | 0.130 |
Why?
|
Analysis of Variance | 4 | 2013 | 6230 | 0.130 |
Why?
|
Leukocyte Count | 1 | 2019 | 1596 | 0.120 |
Why?
|
Glutamates | 1 | 2016 | 389 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2023 | 879 | 0.120 |
Why?
|
Fatty Acids | 1 | 2022 | 1804 | 0.120 |
Why?
|
Survival Analysis | 5 | 2019 | 10074 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2023 | 1197 | 0.120 |
Why?
|
Nutrition Surveys | 3 | 2017 | 1721 | 0.120 |
Why?
|
Colistin | 1 | 2014 | 44 | 0.120 |
Why?
|
beta-Lactam Resistance | 1 | 2014 | 75 | 0.110 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2015 | 142 | 0.110 |
Why?
|
Glutathione | 1 | 2016 | 583 | 0.110 |
Why?
|
Bone Remodeling | 1 | 2017 | 581 | 0.110 |
Why?
|
Peritonitis | 1 | 2016 | 369 | 0.110 |
Why?
|
Carbapenems | 1 | 2014 | 123 | 0.110 |
Why?
|
Conflict of Interest | 1 | 2018 | 554 | 0.110 |
Why?
|
Purines | 1 | 2016 | 605 | 0.110 |
Why?
|
Survival Rate | 2 | 2018 | 12697 | 0.110 |
Why?
|
Inpatients | 2 | 2015 | 2544 | 0.110 |
Why?
|
Metabolic Diseases | 1 | 2019 | 681 | 0.100 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2014 | 237 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39067 | 0.100 |
Why?
|
Physical Therapy Modalities | 1 | 2016 | 536 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1517 | 0.100 |
Why?
|
Comorbidity | 2 | 2017 | 10491 | 0.100 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2242 | 0.100 |
Why?
|
Endocarditis | 1 | 2015 | 350 | 0.100 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1459 | 0.100 |
Why?
|
Thinness | 1 | 2015 | 490 | 0.090 |
Why?
|
Waiting Lists | 1 | 2016 | 764 | 0.090 |
Why?
|
Blood Glucose | 2 | 2017 | 6378 | 0.090 |
Why?
|
Preoperative Care | 1 | 2020 | 2242 | 0.090 |
Why?
|
Gait | 1 | 2016 | 816 | 0.090 |
Why?
|
Social Class | 2 | 2017 | 2003 | 0.090 |
Why?
|
Pneumonia, Bacterial | 1 | 2013 | 316 | 0.090 |
Why?
|
Myocardium | 1 | 2003 | 4698 | 0.090 |
Why?
|
Renal Dialysis | 2 | 2016 | 1792 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2021 | 2632 | 0.090 |
Why?
|
Trauma Centers | 1 | 2016 | 937 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2016 | 809 | 0.090 |
Why?
|
Bone Density Conservation Agents | 1 | 2017 | 795 | 0.090 |
Why?
|
Polymerase Chain Reaction | 3 | 2004 | 6070 | 0.090 |
Why?
|
Surgery Department, Hospital | 1 | 2011 | 176 | 0.080 |
Why?
|
Hospitals, University | 1 | 2011 | 564 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1365 | 0.080 |
Why?
|
Reperfusion Injury | 1 | 2015 | 1023 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 11906 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 7995 | 0.080 |
Why?
|
Mice, Inbred C57BL | 7 | 2015 | 22127 | 0.080 |
Why?
|
Transcription, Genetic | 1 | 2002 | 7595 | 0.080 |
Why?
|
Potassium | 1 | 2012 | 1311 | 0.080 |
Why?
|
Diagnostic Tests, Routine | 1 | 2014 | 785 | 0.080 |
Why?
|
Transplantation, Homologous | 4 | 2004 | 4808 | 0.070 |
Why?
|
Bacterial Infections | 1 | 2016 | 1406 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3629 | 0.070 |
Why?
|
Respiratory Tract Infections | 1 | 2015 | 1008 | 0.070 |
Why?
|
Gene Deletion | 2 | 2004 | 2667 | 0.070 |
Why?
|
Motor Activity | 1 | 2016 | 2687 | 0.070 |
Why?
|
Cytokines | 4 | 2004 | 7378 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2018 | 3540 | 0.060 |
Why?
|
Forecasting | 1 | 2015 | 2925 | 0.060 |
Why?
|
Diet | 1 | 2024 | 8046 | 0.060 |
Why?
|
Transplantation, Isogeneic | 2 | 2003 | 248 | 0.060 |
Why?
|
Recovery of Function | 1 | 2016 | 2975 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10174 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1934 | 0.060 |
Why?
|
ROC Curve | 1 | 2013 | 3570 | 0.060 |
Why?
|
General Surgery | 1 | 2016 | 1687 | 0.060 |
Why?
|
Genes, T-Cell Receptor | 1 | 2004 | 30 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2003 | 3778 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2016 | 2332 | 0.060 |
Why?
|
beta 2-Microglobulin | 1 | 2004 | 329 | 0.060 |
Why?
|
Residual Volume | 1 | 2023 | 41 | 0.060 |
Why?
|
Sodium Selenite | 1 | 2023 | 11 | 0.050 |
Why?
|
Adolescent | 5 | 2020 | 88173 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2459 | 0.050 |
Why?
|
Transplantation Immunology | 1 | 2004 | 532 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2004 | 344 | 0.050 |
Why?
|
Erythrocytes | 1 | 2011 | 2417 | 0.050 |
Why?
|
Qualitative Research | 1 | 2012 | 3008 | 0.050 |
Why?
|
Glomerular Filtration Rate | 2 | 2024 | 2171 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2003 | 526 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9304 | 0.050 |
Why?
|
Animals | 11 | 2015 | 168245 | 0.050 |
Why?
|
Incidence | 2 | 2016 | 21308 | 0.050 |
Why?
|
Mice | 9 | 2007 | 81406 | 0.050 |
Why?
|
Models, Statistical | 1 | 2015 | 5075 | 0.040 |
Why?
|
Prospective Studies | 3 | 2023 | 54304 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2004 | 1445 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2004 | 1494 | 0.040 |
Why?
|
Tetrahydrofolates | 1 | 2000 | 58 | 0.040 |
Why?
|
Public Health | 1 | 2013 | 2663 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3240 | 0.040 |
Why?
|
Hyperhomocysteinemia | 1 | 2000 | 118 | 0.040 |
Why?
|
Interleukins | 1 | 2004 | 782 | 0.040 |
Why?
|
Iatrogenic Disease | 1 | 2022 | 538 | 0.040 |
Why?
|
Israel | 1 | 2021 | 722 | 0.040 |
Why?
|
Young Adult | 4 | 2020 | 59054 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 835 | 0.040 |
Why?
|
Stomach | 1 | 2023 | 694 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7813 | 0.040 |
Why?
|
Models, Animal | 1 | 2004 | 2112 | 0.040 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2019 | 362 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2007 | 3207 | 0.040 |
Why?
|
Micronutrients | 1 | 2020 | 381 | 0.040 |
Why?
|
Osteocalcin | 1 | 2017 | 274 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20076 | 0.030 |
Why?
|
Mice, Knockout | 4 | 2004 | 14400 | 0.030 |
Why?
|
Phosphates | 1 | 2020 | 771 | 0.030 |
Why?
|
United States | 4 | 2018 | 72181 | 0.030 |
Why?
|
Antigens, CD | 2 | 2004 | 4000 | 0.030 |
Why?
|
Cell Communication | 1 | 2003 | 1653 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7423 | 0.030 |
Why?
|
Kinetics | 1 | 2002 | 6375 | 0.030 |
Why?
|
Up-Regulation | 1 | 2003 | 4115 | 0.030 |
Why?
|
Heart Failure | 1 | 2018 | 11647 | 0.030 |
Why?
|
Regression Analysis | 1 | 2024 | 6336 | 0.030 |
Why?
|
Calcifediol | 1 | 2015 | 161 | 0.030 |
Why?
|
Calcitriol | 1 | 2015 | 297 | 0.030 |
Why?
|
Folic Acid | 1 | 2000 | 1313 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1806 | 0.030 |
Why?
|
Receptors, Nerve Growth Factor | 2 | 2004 | 198 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3705 | 0.030 |
Why?
|
Independent Living | 1 | 2017 | 577 | 0.030 |
Why?
|
Pulmonary Alveoli | 1 | 2015 | 651 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2003 | 4353 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2003 | 3468 | 0.020 |
Why?
|
Energy Intake | 1 | 2019 | 2133 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2024 | 3187 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2004 | 3028 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5861 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2004 | 9532 | 0.020 |
Why?
|
Mice, Inbred Strains | 2 | 2004 | 1759 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2004 | 584 | 0.020 |
Why?
|
Esophagectomy | 1 | 2015 | 465 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2021 | 2092 | 0.020 |
Why?
|
History, 21st Century | 1 | 2017 | 1567 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2002 | 3060 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3115 | 0.020 |
Why?
|
Collagen | 1 | 2017 | 2637 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4167 | 0.020 |
Why?
|
Kidney | 1 | 2024 | 7046 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10188 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3800 | 0.020 |
Why?
|
Research Design | 1 | 2022 | 6165 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 305 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2004 | 5663 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2003 | 3157 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2017 | 5104 | 0.020 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2004 | 39 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 26043 | 0.010 |
Why?
|
Bone Density | 1 | 2017 | 3549 | 0.010 |
Why?
|
STAT4 Transcription Factor | 1 | 2003 | 93 | 0.010 |
Why?
|
4-1BB Ligand | 1 | 2003 | 29 | 0.010 |
Why?
|
Hypertension | 1 | 2024 | 8527 | 0.010 |
Why?
|
Genes, RAG-1 | 1 | 2003 | 67 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2003 | 193 | 0.010 |
Why?
|
Algorithms | 1 | 2004 | 13990 | 0.010 |
Why?
|
Lymphocyte Transfusion | 1 | 2004 | 232 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3684 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3667 | 0.010 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2003 | 149 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2007 | 4574 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2004 | 910 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18218 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4024 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13483 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2003 | 1704 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18960 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3218 | 0.010 |
Why?
|
Th1 Cells | 1 | 2003 | 1037 | 0.010 |
Why?
|
Th2 Cells | 1 | 2003 | 1054 | 0.010 |
Why?
|
Spleen | 1 | 2004 | 2296 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15689 | 0.010 |
Why?
|
Homocysteine | 1 | 2000 | 638 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2004 | 1611 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2004 | 2712 | 0.010 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 9590 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1960 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2004 | 1806 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2007 | 4371 | 0.010 |
Why?
|
Asthma | 1 | 2013 | 6203 | 0.010 |
Why?
|
Trans-Activators | 1 | 2003 | 2859 | 0.010 |
Why?
|
Treatment Failure | 1 | 2000 | 2642 | 0.010 |
Why?
|
Administration, Oral | 1 | 2000 | 4010 | 0.010 |
Why?
|
Child | 1 | 2020 | 80070 | 0.010 |
Why?
|
Gene Expression | 1 | 2004 | 7586 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11073 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2000 | 10758 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15454 | 0.000 |
Why?
|